Whole‐Genome Bisulfite Sequencing Identifies Blood‐Based DNA Methylation Biomarker for Hepatocellular Carcinoma

Documenti analoghi

• Correction to “Plasma DNA Methylation‐Based Biomarkers for MPNST Detection in Patients With Neurofibromatosis Type 1”
  Pubblicazione: (2025)
• Clinical and Genomic Phenotype of Brain Metastasis in Nasopharyngeal Carcinoma
  di: Ying‐peng Peng, et al.
  Pubblicazione: (2024)
• ZMYM4 Acts as a Potential Prognostic Biomarker and Promotes the Malignant Progression of Hepatocellular Carcinoma Cells: It Is Regulated by miR‐34a‐5p
  di: Qilin Yi, et al.
  Pubblicazione: (2025)
• Monocarboxylate Transporter‐1 Is Dispensable for Hepatocellular Carcinoma Development
  di: Shaimaa A. Gad, et al.
  Pubblicazione: (2025)
• The 5‐Methylcytosine RNA Modification in Hepatitis B Virus‐Negative Hepatocellular Carcinoma: Insights From Long‐Read Nanopore Sequencing
  di: Tianhan Sun, et al.
  Pubblicazione: (2026)